Boom in the Lone Star State: Bristol Myers Squibb Unveils $2.3 Billion Mega-Plant in Houston, Redefining American Biomanufacturing
HOUSTON, TEXAS — In a landmark development that solidifies Texas’s status as an emerging heavyweight in the global life sciences sector, pharmaceutical giant Bristol Myers Squibb (BMS) has officially announced a massive $2.3 billion investment to construct a state-of-the-art manufacturing, research, and development campus in Houston. This ambitious project is designed to drastically accelerate the […]
Continue Reading